Allergic contact dermatitis from 2-bromo-2-nitropropane-1,3-diol in Metrogel.
Choudry
K
K
Contact Dermatitis Investigation Unit, The Dermatology Centre, University of, Manchester School of Medicine, Hope Hospital, Salford, Lancs M6 8HD, UK.
Beck
M H
MH
Muston
H L
HL
D000485:Allergens / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000209:etiology*; D005260:Female; D005782:Gels; D006801:Humans; D008795:Metronidazole / Q000009:adverse effects* / Q000737:chemistry; D008875:Middle Aged; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects*; D011409:Propylene Glycols / Q000009:adverse effects*
D000485:Allergens; D000890:Anti-Infective Agents; D005782:Gels; D011310:Preservatives, Pharmaceutical; D011409:Propylene Glycols; D008795:Metronidazole; C006827:bronopol